LataMed AI Partners with Venezuelan Pharmacies for AI Fulfillment

LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, has reached commercial terms with two leading pharmacy retail operators in Caracas, Venezuela, to support the planned deployment of its AI-powered prescription processing and pharmaceutical fulfillment platform. This initiative is part of the company's broader Latin American commercialization strategy, aiming to establish an initial operational framework for its expanding AI-driven healthcare logistics ecosystem. Venezuela was selected as the initial target market due to increasing interest in technology-enabled healthcare infrastructure and opportunities for modernization in the pharmaceutical distribution sector. The platform is designed to streamline prescription fulfillment through mobile-enabled intake, AI-based text recognition, automated inventory verification, fulfillment coordination, and delivery routing, addressing operational inefficiencies in underserved Latin American healthcare markets.

The planned deployment aims to improve prescription processing efficiency, reduce administrative overhead, optimize pharmacy inventory coordination, and enhance customer accessibility for participating pharmacy operators. Management believes this initiative provides key commercial advantages, including entry into a major Latin American metropolitan market, real-world evaluation of the platform, potential recurring transaction-based revenue from prescription volumes, and a scalable framework for future expansion across South America. The pharmacy fulfillment platform is intended to integrate with LataMed's broader digital healthcare ecosystem, which includes telehealth applications, healthcare analytics, patient engagement technologies, and AI-assisted coordination platforms. Dr. Kevin Rodan Levy, CEO of LataMed AI Corp., stated that pharmacy fulfillment is a natural extension of their digital healthcare infrastructure strategy, combining AI-enabled processing, logistics, and retail participation to support accessibility and scalability in Latin America.

However, the company emphasized that the platform's deployment remains subject to operational planning, technology integration, commercial readiness, regulatory considerations, partner timelines, financing availability, and market adoption. No assurance can be provided regarding the timing of commercial deployment, transaction volumes, revenue generation, or geographic expansion. LataMed AI Corp. continues to advance telehealth initiatives, healthcare analytics integration, and strategic relationships as part of its long-term digital healthcare ecosystem strategy. For more information, visit the company's website at https://latamed.ai or follow its official Instagram page at https://www.instagram.com/latamedai. The original release can be found on NEWMEDIAWIRE.